Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Temozolomide in Recurrent Malignant Glioma
NCT00990652Phase 2Completed
- Sponsor
- Northwestern University
- Start
- May 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in malignant glioma, sponsored by Northwestern University. Started May 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00990652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990652.